Angiotensin-converting enzyme inhibitors improve nephrosis more quickly than calcium antagonists in diabetic patients.
Fujita
T
T
Satomura
A
A
Hidaka
M
M
Ohsawa
I
I
Endo
M
M
Ohi
H
H
D000328:Adult; D017311:Amlodipine / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001794:Blood Pressure / Q000502:physiology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D017315:Cilazapril / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D005260:Female; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009401:Nephrosis / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D011446:Prospective Studies; D011507:Proteinuria / Q000188:drug therapy; D012079:Renal Circulation
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D017315:Cilazapril; D017311:Amlodipine